Pacira Pharmaceuticals (PCRX) Files $150M Mixed Shelf
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Join SI Premium – FREE
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Units, or any combination thereof.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Singularity Future Technology closes $5M registered direct offering
- Silexion Therapeutics faces Nasdaq delisting over equity shortfall
- Elroy Air wins $46M U.S. Army contract for cargo drone system
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
